Suppression of dialysis patients' lumphocyte IL-2R expression by glucocorticoids and cyclosporine

Cytokine

Volumn 9, Issue 8, 1997, Pages 624-628

  Briggs, William A ^a   Gao, Zu Hua ^a   Xing, Jing Jing ^a   Scheel, Paul J ^a   Gimenez, Luis F ^a   Samaniego, Milagros D ^a   Choi, Michael J ^a   Burdick, James F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclosporine; Glucocorticoids; Interleukin 2 receptor; Lymphocyte

Indexed keywords

CYCLOSPORIN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR; METHYLPREDNISOLONE; PREDNISOLONE;

ARTICLE; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PERITONEAL DIALYSIS; PRIORITY JOURNAL;

EID: 0031213624     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1997.0210     Document Type: Article

References (25)

1. 1. Hirano T, Oka K, Takeuchi H, Sakurai E, Matsuno N, Tamaki T, Kozaki M (1994) Clinical significance of glucocorticoid pharmacodynamics assessed by antilymphocyte action in kidney transplantation. Marked difference between prednisolone and methylprednisolone. Transplantation 57:1341-1348.
2. 2. House AK, Potter JM, Walker KB (1986) Prednisolone and rejection: suppressed lymphocyte blastogenesis and allograft rejection. Transplant Proc 8:211-214.
3. 3. Langhoff E, Jakobsen BK, Ryder LP, Ladefoged J, Platz P, Svejgaard A, Thayson JH (1986) Recipient lymphocyte sensitivity to methylprednisolone affects cadaver kidney graft survival. Lancet i:1286-1297.
4. 4. Langhoff E, Ladefoged J (1987) The impact of high lymphocyte sensitivity to glucocorticoids on kidney graft survival in patients treated with azathioprine and cyclosporine. Transplantation 43:380-384.
5. 5. Kang X-X, Hirano T, Oka K, Sakurai E, Tamaki T, Kozaki M (1991) Role of altered prednisolone-specific lymphocyte sensitivity in chronic renal failure as a pharmacodynamic marker of acute allograft rejection after kidney transplantation. Eur J Clin Pharmacol 41:417-423.
6. 6. Briggs WA, Gao Z-H, Scheel PJ, Burdick JF, Gimenez LF, Choi MJ (1996) Differential glucocorticoid responsiveness of dialysis patients' lymphocytes. Perit Dial Int 16:406-411.
7. 7. Frey BM, Frey WFJ, deWeck AL (1984) Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function. J Immunol 133:2479-2487.
8. 8. Ost L, Bjorkhem I, von Bahr C (1984) Clinical value of assessing prednisolone pharmacokinetics before and after renal transplantation. Eur J Clin Pharmacol 133:363-369.
9. 9. Lindholm A, Kahan BD (1993) Influence of cyclosporine pharmacokinetics, trough concentrations and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 54:205-218.
10. 10. Briggs, WA, Gao Z-H, Gimenez LF, Scheel PJ, Choi MJ, Burdick JF (1996) Lymphocyte responsiveness to glucocorticoids, cyclosporine, or both. J Clin Pharmacol 36:707-714.
11. 11. Langhoff E, Olgaard K, Ladefoged J (1983) Relative immunosuppressive potency of various corticosteroids measured in vitro. Euro J Clin Pharmacol 25:459-462.
12. 12. Langhoff E, Olgaard K, Ladefoged J (1987) The immunosuppressive potency in vitro of physiological and synthetic steroids on lymphocyte cultures. Int J Immunopharmacol 9:469-473.
13. 13. Adcock IM, Lane SJ, Brown CR, Peters MJ, Lee TH, Barnes PJ (1995) Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. J Immunol 154:3500-3505.
14. 14. Adcock IM, Brown CR, Gelder CM, Shirasaki H, Peters MJ, Barnes PJ (1995) Effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells. Am J Physiol 268 (Cell Physiol 37):C331-C338.
15. 15. Paliogianni F, Boumpas DT (1995) Glucocorticoids regulate calcineurin-dependent transactivating pathways for interleukin 2 gene transcription in human T lymphocytes. Transplantation 59:1333-1339.
16. 16. Boumpas DT, Anastassiou D, Older SA, Tsokos GC, Nelson DL, Balow JE (1991) Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription. J Clin Invest 87:1739-1747.
17. 17. Vacca A, Felli MP, Farina AR, et al. (1992) Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements. J Exp Med 175:637-646.
18. 18. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin Jr AS (1995) Role of transcriptional activation of IκBα in mediation of immunosuppression of glucocorticoids. Science 270:283-286.
19. 19. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NFκB activity through induction of IκBα synthesis. Science 270:286-290.
20. 20. Schwiebert LM, Schleimer RP, Radka SF, Ono SJ (1995) Modulation of MHC class II expression in human cells by dexamethasone. Cell Immunol 165:12-19.
21. 21. Ayanlar Batuman O, Ferrero AP, Diaz A, Jimenez SA (1991) Regulation of transforming growth factor-β1 gene expression by glucocorticoids in normal human T lymphocytes. J Clin Invest 88:1574-1580.
22. 22. Liu J (1993) FK 506 and cyclosporine, molecular probes for studying intracellular signal transduction. Immunol Today 14: 290-295.
23. 23. Khanna A, Li B, Stenzel KH, Suthanthiran M (1994) Regulation of new DNA synthesis in mammalian cells by cyclosporine. Transplantation 57:577-582.
24. 24. Poznansky MC, Gordon ACH, Douglas JG, Krajewski AS, Wyllie AH, Grant IWB (1984) Resistance to methylprednisolone in cultures of blood mononuclear cells from glucocorticoid-resistant asthmatic patients. Clin Sci (London) 67:639-645.
25. 25. Kirkam BW, Corkill MM, Davison SC, Panayi GS (1991) Response to glucocorticoid treatment in rheumatoid arthritis: in vitro mediated immune assay predicts in vivo responses. J Rheumatol 18:821-825.